ask="6.32"
ask_size="700"
average_daily_volume="969037"
bid="6.00"
bid_size="1000"
book_value="0.05"
change="+0.26"
change_from_200_day_moving_average="1.36"
change_from_50_day_moving_average="-0.00"
change_from_52_week_high="-1.26"
change_From_52_week_low="4.67"
change_in_percent="+4.30%"
close="6.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.93"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.86"
ex_dividend_date="N/A"
float_shares="42554000"
high="6.32"
high_52_weeks="7.56"
last_trade_date="1/31/2017"
last_trade_price="6.30"
last_trade_size="63420"
last_trade_time="4:00pm"
low="5.87"
low_52_weeks="1.63"
market_capitalization="464.68M"
moving_average_200_day="4.94"
moving_average_50_day="6.30"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="6.00"
pe_ratio="N/A"
peg_ratio="-0.35"
percent_change_from_200_day_moving_average="+27.61%"
percent_change_from_50_day_moving_average="-0.01%"
percent_change_from_52_week_high="-16.67%"
percent_change_from_52_week_low="+286.50%"
previous_close="6.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="111.85"
price_per_sales="20.28"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="6.39"
stock_exchange="NMS"
symbol="BCRX"
volume="639489"
weeks_range_52="1.63 - 7.56"
